Related references
Note: Only part of the references are listed.Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion
Pavan Bachireddy et al.
BLOOD (2014)
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial
Jason R. Westin et al.
LANCET ONCOLOGY (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
Andrea Schietinger et al.
TRENDS IN IMMUNOLOGY (2014)
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients
M. Foglietta et al.
BONE MARROW TRANSPLANTATION (2013)
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute E. Burkhardt et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
HLA-DPB1*05:01-restricted WT1 332-specific TCR-transduced CD4+ T Lymphocytes Display a Helper Activity for WT1-specific CTL Induction and a Cytotoxicity Against Leukemia Cells
Yuhung Lin et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccine
T. Maeda et al.
BLOOD CANCER JOURNAL (2013)
Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy
L. Qin et al.
BLOOD CANCER JOURNAL (2013)
Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study
Pauline Meij et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
Alfons J. M. van den Eertwegh et al.
LANCET ONCOLOGY (2012)
WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission
Y. Hashii et al.
LEUKEMIA (2012)
Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
A. Tsuboi et al.
LEUKEMIA (2012)
CTLA-4 Blockade following Relapse of Malignancy after Allogeneic Stem Cell Transplantation Is Associated with T Cell Activation But Not with Increased Levels of T Regulatory Cells
Jiehua Zhou et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Peptide vaccine therapy for leukemia
K. Rezvani
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
Lukas Baitsch et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Posttransplantation Vaccination: Concepts Today and on the Horizon
Katayoun Rezvani
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
Peter G. Maslak et al.
BLOOD (2010)
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
Edus H. Warren et al.
BLOOD (2010)
Peptide Length Extension Skews the Minor HA-1 Antigen Presentation toward Activated Dendritic Cells but Reduces Its Presentation Efficiency
Lothar Hambach et al.
JOURNAL OF IMMUNOLOGY (2010)
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
Viggo F. Van Tendeloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
Asad Bashey et al.
BLOOD (2009)
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)
Ivan M. Borrello et al.
BLOOD (2009)
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
Ulrich Keilholz et al.
BLOOD (2009)
Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression
Sabine Mumprecht et al.
BLOOD (2009)
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation
Vincent T. Ho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Potential of dendritic cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole limpet hemocyanin-pulsed, donor-derived dendritic cell vaccine for acute myeloid leukemia
Toshio Kitawaki et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Dendritic cell vaccines in acute leukaemia
Caroline Duncan et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia
Concetta Quintarelli et al.
BLOOD (2008)
Phase 1/2 dose-escalation study of a GM-CSF-Secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
Celestial S. Higano et al.
CANCER (2008)
DNA vaccines: precision tools for activating effective immunity against cancer
Jason Rice et al.
NATURE REVIEWS CANCER (2008)
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
Katayoun Rezvani et al.
BLOOD (2008)
T cell immune reconstitution following lymphodepletion
Kirsten A. Williams et al.
SEMINARS IN IMMUNOLOGY (2007)
Graft-versus-leukemia effects associated with detectable Wilms tumor-1-specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia
Katayoun Rezvani et al.
BLOOD (2007)
Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions
Yoshiki Akatsuka et al.
CANCER SCIENCE (2007)
Identification and characterization of a WT1 (Wilms tumor gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes
Fumihiro Fujiki et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation
Yuriko Morita et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
DNA fusion vaccines induce epitope-specific cytotoxic CD8+ T cells against human leukemia-associated minor histocompatibility antigens
Jason Rice et al.
CANCER RESEARCH (2006)
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation
RF Rousseau et al.
BLOOD (2006)
Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice
L Hambach et al.
LEUKEMIA (2006)
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
M Bendandi et al.
LEUKEMIA & LYMPHOMA (2006)
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX (R) vaccine in advanced-stage non-small-cell lung cancer
J Nemunaitis et al.
CANCER GENE THERAPY (2006)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Regulation of mature T cell homeostasis
CD Surh et al.
SEMINARS IN IMMUNOLOGY (2005)
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Y Oka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation
K Rezvani et al.
BLOOD (2003)
Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis
Y Oka et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Human cytotoxic T lymphocytes specific for Wilms' tumor antigen-1 inhibit engraftment of leukemiainitiating stem cells in non-obese diabetic-severe combined immunodeficient recipients
LQ Gao et al.
TRANSPLANTATION (2003)
Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation
J Michálek et al.
LANCET (2003)
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
WAE Marijt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes
S Slavin et al.
BONE MARROW TRANSPLANTATION (2001)
Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes
SRM Clarke et al.
JOURNAL OF IMMUNOLOGY (2000)
Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells
BK Cho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Cancer immunotherapy targeting Wilms' tumor gene WT1 product
Y Oka et al.
JOURNAL OF IMMUNOLOGY (2000)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem et al.
NATURE MEDICINE (2000)
Share Paper
